Cryoport Inc receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Cryoport Inc (CYRX)
Cryoport Inc stock price live, this page displays NASDAQ CYRX stock exchange data. View the CYRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Cryoport Inc real time stock price chart below.
What Is the Cryoport Inc Stock Price Today?
The Cryoport Inc stock price today is 8.09.
What Is the Stock Symbol for Cryoport Inc?
The stock symbol for Cryoport Inc is "CYRX."
What Stock Exchange Does Cryoport Inc Trade On?
Cryoport Inc is listed and trades on the NASDAQ stock exchange.
Is Cryoport Inc a Good Stock to Buy?
Determining whether Cryoport Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYRX quote. (ISIN: US2290503075)
What Is the Cryoport Inc Stock Price Today?
The Cryoport Inc stock price today is 8.09.
What Is the Stock Symbol for Cryoport Inc?
The stock symbol for Cryoport Inc is "CYRX."
What Stock Exchange Does Cryoport Inc Trade On?
Cryoport Inc is listed and trades on the NASDAQ stock exchange.
Is Cryoport Inc a Good Stock to Buy?
Determining whether Cryoport Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CYRX quote. (ISIN: US2290503075)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.04
8.45
52 wk Range
4.63
11.45
CYRX is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
8.048.45
52 wk Range
4.6311.45
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
CYRX Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Strong Buy
Price Target
13.33
Upside
+64.81%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
3 analysts have revised their earnings downwards for the upcoming period
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell
Cryoport Inc Company Profile
Cryoport, Inc. provides temperature-controlled supply chain solutions in biopharma/pharma, animal health, and reproductive medicine markets worldwide. The company’s Life Sciences Services segment provides temperature-controlled logistics and biostorage, bioservices and cryopreservation services within the life science industry. Its Life Sciences Products segment manufactures, and sells offers cryogenic freezers, cryogenic dewars, and related ancillary accessories within the life science industry through direct sales or a distribution network. The company’s products include Cryoport Express Shippers; Cryoport Elite; Cryoport Express Cryogenic HV3 Shipping System; Smartpak Condition Monitoring System and Tec4Med, an IoT-based monitoring solutions; and Cryoport accessories. It also provides Cryoport BioStorage/Bioservices, such as Cryoport Systems Bioservices, including controlled temperature storage, kitting, labelling, fulfillment, sample management, drug return, and Qualified Person drug product release. In addition, the company offers IntegriCell services that comprise apheresis/leukapheresis collection, cryoshuttle transportation, cryo-process optimization, and cryopreservation services; Cryoport consulting services; MVE Fusion cryogenic system, a self-sustaining cryogenic freezer; and MVE Vario cryogenic system, a cryogenic freezer system. Further, it provides biological specimen cryopreservation storage and maintenance; archiving, monitoring, tracking, receipt, and delivery of samples; frozen biological specimens transportation; incoming and outgoing biological specimens management; and short-term logistics and engineering consulting services. The company was founded in 1999 and is based in Brentwood, Tennessee.
Cryoport Inc SWOT Analysis
Cryoport's Crossroads | Explore Cryoport's strategic position in cold chain logistics, facing growth challenges amidst a declining stock price and market capitalization of $388 million |
Financial Headwinds | Delve into Cryoport's revised revenue guidance and cost-cutting measures, aiming for adjusted EBITDA profitability by 2025 despite recent downward trends |
Market Dynamics | Analyst targets range from $8 to $15 per share, reflecting mixed views on Cryoport's potential in the evolving cell and gene therapy secto |
Future Trajectory | Learn how new FDA approvals and cost reduction initiatives could reshape Cryoport's growth prospects, balancing against ongoing challenges in key segments |
Cryoport Inc Earnings Call Summary for Q4/2025
- Q4 2025 revenue hit $45.45M, beating forecast by 5.87%; EPS missed at -$0.27 vs. expected -$0.21, down 28.57%
- Full-year revenue reached $176.2M; commercial cell & gene therapy revenue surged 29% YoY, supporting record 760 clinical trials
- Stock declined 2.19% to $8.03 in aftermarket trading despite revenue beat, reflecting investor concern over profitability miss
- Company projects 2026 revenue of $190M-$194M (~8% growth); expects positive adjusted EBITDA in second half of 2026
- Adjusted EBITDA improved $12M YoY; gross margin at 47% for 2025, with focus on cost reduction and strategic partnerships
Last Updated: 2026-03-03, 06:26 p/m
Read Full TranscriptCompare CYRX to Peers and Sector
Metrics to compare | CYRX | Sector Sector - Average of metrics from a broad group of related Industrials sector companies | Relationship RelationshipCYRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −9.6x | −0.2x | −0.5x | |
PEG Ratio | −0.06 | 0.06 | 0.00 | |
Price/Book | 0.8x | 1.0x | 2.6x | |
Price / LTM Sales | 2.3x | 1.8x | 3.2x | |
Upside (Analyst Target) | 60.7% | 43.2% | 51.4% | |
Fair Value Upside | Unlock | 26.6% | 8.5% | Unlock |
Analyst Ratings
8 Buy
1 Hold
0 Sell
Ratings:
9 analysts
Overall Consensus
Strong Buy
Analysts 12-Month Price Target:
Average 13.33
(+64.81% Upside)
Earnings
Latest Release
Mar 03, 2026
EPS / Forecast
-0.27 / -0.21
Revenue / Forecast
45.45M / 42.93M
People Also Watch
FAQ
What Is the Cryoport Inc (CYRX) Stock Price Today?
The Cryoport Inc stock price today is 8.09 USD.
What Stock Exchange Does Cryoport Inc Trade On?
Cryoport Inc is listed and trades on the Nasdaq Stock Exchange.
What Is the Stock Symbol for Cryoport Inc?
The stock symbol for Cryoport Inc is "CYRX."
What Is the Cryoport Inc Market Cap?
As of today, Cryoport Inc market cap is 403.34M USD.
What Is Cryoport Inc's Earnings Per Share (TTM)?
The Cryoport Inc EPS (TTM) is -0.84.
When Is the Next Cryoport Inc Earnings Date?
Cryoport Inc will release its next earnings report on Apr 30, 2026.
From a Technical Analysis Perspective, Is CYRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Cryoport Inc Stock Split?
Cryoport Inc has split 2 times.
How Many Employees Does Cryoport Inc Have?
Cryoport Inc has 1098 employees.
What is the current trading status of Cryoport Inc (CYRX)?
As of Mar 07, 2026, Cryoport Inc (CYRX) is trading at a price of 8.09 USD, with a previous close of 8.36 USD. The stock has fluctuated within a day range of 8.04 USD to 8.45 USD, while its 52-week range spans from 4.63 USD to 11.45 USD.
What Is Cryoport Inc (CYRX) Price Target According to Analysts?
The average 12-month price target for Cryoport Inc is 13.33 USD, with a high estimate of 16 USD and a low estimate of 9.5 USD. 8 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +64.81% Upside potential.
What Is the CYRX Premarket Price?
CYRX's last pre-market stock price is 7.60 USD. The pre-market share volume is 1,360.00, and the stock has decreased by -0.76, or -9.09%.
What Is the CYRX After Hours Price?
CYRX's last after hours stock price is 8.05 USD, the stock has decreased by -0.04, or -0.49%.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.